China has approved the world’s first commercial brain implant, enabling paralyzed patients to regain movement and positioning the country ahead in the global neurotechnology race.
China has approved the world’s first commercial brain-computer interface (BCI) implant, beating competitors like Elon Musk’s Neuralink to market. The device, known as NEO, was developed by Shanghai-based Neuracle Medical Technology and authorised for public use by Chinese regulators after successful clinical trials involving 32 paralyzed patients.
Unlike more invasive systems, the NEO implant sits on the brain’s surface rather than penetrating tissue, reducing risks. The device works by decoding brain signals and transmitting them to a robotic glove, enabling users with paralysis to perform actions like grasping objects and drinking independently after years of immobility.
Researchers say the technology may go beyond assistive function, potentially helping the nervous system recover over time. With government backing, China aims to lead the global BCI industry, while similar technologies in the United States remain in clinical trial stages without commercial approval.
NEWS NOW:
- The five big sticking points in US-Iran talks
- “I had the opportunity to take out Charlie Kirk, and I took it” Unsealed court document reveals the content of a note from Tyler Robinson, the man accused of killing conservative activist Charlie kirk
- Discovering the Top Pokies Experiences in Wangaratta
- There can only be one reason for Melania talking Epstein. It’s not good